Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2053 ARTíCULOS , VIENDO DEL 1621 AL 1635

PUBMED

A Narrative Review of Specialist Parkinson's Nurses: Evolution, Evidence and Expectation

Tenison E, James A, Ebenezer L, Henderson EJ.

Geriatrics (Basel). 2022 Apr 7;7(2):46. doi: 10.3390/geriatrics7020046.

0

0

0

PUBMED

Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase

Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K.

Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.

0

0

0

PUBMED

The neuroinflammatory role of glucocerebrosidase in Parkinson's disease

Bo RX, Li YY, Zhou TT, Chen NH, Yuan YH.

Neuropharmacology. 2022 Apr 1;207:108964. doi: 10.1016/j.neuropharm.2022.108964. Epub 2022 Jan 19.

0

0

0

PUBMED

Medications used to treat tremors

Frei K, Truong DD.

J Neurol Sci. 2022 Apr 15;435:120194. doi: 10.1016/j.jns.2022.120194. Epub 2022 Feb 19.

0

0

0

PUBMED

Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases

Mohd Murshid N, Aminullah Lubis F, Makpol S.

Cell Mol Neurobiol. 2022 Apr;42(3):577-595. doi: 10.1007/s10571-020-00979-z. Epub 2020 Oct 19.

0

0

0

PUBMED

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

Bohnen NI, Yarnall AJ, Weil RS, Moro E, Moehle MS, Borghammer P, Bedard MA, Albin RL.

Lancet Neurol. 2022 Apr;21(4):381-392. doi: 10.1016/S1474-4422(21)00377-X. Epub 2022 Feb 4.

0

0

0

PUBMED

Immunogenetic Determinants of Parkinson's Disease Etiology

Kung PJ, Elsayed I, Reyes-Pérez P, Bandres-Ciga S.

J Parkinsons Dis. 2022 Mar 31. doi: 10.3233/JPD-223176. Online ahead of print.

0

0

0

PUBMED

Eye Movement Disorders in Movement Disorders

Kassavetis P, Kaski D, Anderson T, Hallett M.

Mov Disord Clin Pract. 2022 Feb 16;9(3):284-295. doi: 10.1002/mdc3.13413. eCollection 2022 Apr.

0

0

0

PUBMED

Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis

Lu S, Jiang HY, Shi YD.

Acta Neurol Scand. 2022 Apr;145(4):442-448. doi: 10.1111/ane.13570. Epub 2021 Dec 15.

0

0

0

PUBMED

Niemann-Pick disease type B and Parkinson's disease: a coexistence or an etiological association?

Onder H, Kocer B, Duzkale N, Comoglu S.

Neurol Sci. 2022 Apr;43(4):2867-2869. doi: 10.1007/s10072-021-05860-5. Epub 2022 Jan 31.

0

0

0

PUBMED

Embedding digital chronotherapy into bioelectronic medicines

Fleming JE, Kremen V, Gilron R, Gregg NM, Zamora M, Dijk DJ, Starr PA, Worrell GA, Little S, Denison TJ.

iScience. 2022 Mar 4;25(4):104028. doi: 10.1016/j.isci.2022.104028. eCollection 2022 Apr 15.

0

0

0

PUBMED

Biomarker of Neuroinflammation in Parkinson's Disease

Liu TW, Chen CM, Chang KH.

Int J Mol Sci. 2022 Apr 8;23(8):4148. doi: 10.3390/ijms23084148.

0

0

0

PUBMED

Botulinum toxin for the treatment of tremor

Mittal SO, Pandey S.

J Neurol Sci. 2022 Apr 15;435:120203. doi: 10.1016/j.jns.2022.120203. Epub 2022 Feb 19.

0

0

0

PUBMED

Including People with Parkinson's Disease in Clinical Study Design and Execution: A Call to Action

Meinders MJ, Donnelly AC, Sheehan M, Bloem BR.

J Parkinsons Dis. 2022 Apr 4. doi: 10.3233/JPD-223190. Online ahead of print.

0

0

0

PUBMED

Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease

Zhang Z, Zhou Y, Zhao H, Xu J, Yang X.

Cell Mol Neurobiol. 2022 Apr;42(3):665-675. doi: 10.1007/s10571-020-00953-9. Epub 2020 Sep 3.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy